The National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) is
responsible for public health surveillance, prevention research, and
programs to prevent and control human immunodeficiency virus (HIV)
infection and acquired immunodeficiency syndrome (AIDS), other sexually
transmitted diseases (STDs), viral hepatitis, and tuberculosis (TB). Center staff work in
collaboration with governmental and nongovernmental partners at
community, State, national, and international levels, applying
well-integrated multidisciplinary programs of research, surveillance,
technical assistance, and evaluation.
Kevin Fenton, M.D., Ph.D., FFPH, is the director of the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP). In November 2005, Dr. Fenton was named director of the National Center for HIV, STD, and TB Prevention, which was renamed NCHHSTP in March 2007 to reflect the addition of CDC’s Viral Hepatitis program. He previously served as chief of CDC’s National Syphilis Elimination Effort since January 2005.
He has worked in research, epidemiology, and the prevention of HIV
and other STDs since 1995 and was previously the Director of the HIV and STI Department at the United Kingdom’s Health Protection Agency. Dr
Fenton has spearheaded the development of a number of national HIV, STD
and behavioral surveillance and research programs in the U.K. and
Western Europe including the National Chlamydia Screening Program in
England, the 2nd British National Survey of Sexual Attitudes and
Lifestyles and the European Surveillance of STI (ESSTI) Network.
He is a Fellow of the Faculty of Public Health of the Royal Colleges of
Physicians of the United Kingdom.
Last Reviewed: 12/19/2007
National Center for HIV/AIDS, Viral
Hepatitis, STD, and TB Prevention